Arunachalam Sekar

Rehovot, M, Israel

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications

TMPRSS2-ERG confers resistance to antiandrogens: mechanism and therapeutic implications.

TMPRSS2-ERG confers resistance to antiandrogens: mechanism and therapeutic implications.

Journal: bioRxiv : the preprint server for biology
Published: June 26, 2025

TMPRSS2-ERG confers resistance of prostate cancer to antiandrogens.

TMPRSS2-ERG confers resistance of prostate cancer to antiandrogens.

Journal: EMBO molecular medicine
Published: June 07, 2025

Re-epithelialization of cancer cells increases autophagy and DNA damage: Implications for breast cancer dormancy and relapse.

Re-epithelialization of cancer cells increases autophagy and DNA damage: Implications for breast cancer dormancy and relapse.

Journal: Science signaling
Published: April 22, 2025

L858R emerges as a potential biomarker predicting response of lung cancer models to anti-EGFR antibodies: Comparison of osimertinib vs. cetuximab.

L858R emerges as a potential biomarker predicting response of lung cancer models to anti-EGFR antibodies: Comparison of osimertinib vs. cetuximab.

Journal: Cell reports. Medicine
Published: September 07, 2022

AXL and Error-Prone DNA Replication Confer Drug Resistance and Offer Strategies to Treat EGFR-Mutant Lung Cancer.

AXL and Error-Prone DNA Replication Confer Drug Resistance and Offer Strategies to Treat EGFR-Mutant Lung Cancer.

Journal: Cancer discovery
Published: January 28, 2022

TSHZ2 is an EGF-regulated tumor suppressor that binds to the cytokinesis regulator PRC1 and inhibits metastasis.

TSHZ2 is an EGF-regulated tumor suppressor that binds to the cytokinesis regulator PRC1 and inhibits metastasis.

Journal: Science signaling
Published: June 23, 2021

Nucleoporin-93 reveals a common feature of aggressive breast cancers: robust nucleocytoplasmic transport of transcription factors.

Nucleoporin-93 reveals a common feature of aggressive breast cancers: robust nucleocytoplasmic transport of transcription factors.

Journal: Cell reports
Published: March 11, 2021

Host-Dependent Phenotypic Resistance to EGFR Tyrosine Kinase Inhibitors.

Host-Dependent Phenotypic Resistance to EGFR Tyrosine Kinase Inhibitors.

Journal: Cancer research
Published: October 22, 2020

PD-L1 recruits phospholipase C and enhances tumorigenicity of lung tumors harboring mutant forms of EGFR.

PD-L1 recruits phospholipase C and enhances tumorigenicity of lung tumors harboring mutant forms of EGFR.

Journal: Cell reports
Published: April 27, 2020

ETS Proteins Bind with Glucocorticoid Receptors: Relevance for Treatment of Ewing Sarcoma.

ETS Proteins Bind with Glucocorticoid Receptors: Relevance for Treatment of Ewing Sarcoma.

Journal: Cell reports
Published: November 18, 2018
Showing 1-10 of 10

Last Updated: 09/26/2026